You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IC31

Showing 1 - 25 of 925
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis Trial in Bergen, Oslo (etoricoxib, H56:IC31)

Completed
  • Tuberculosis
  • Bergen, Norway
  • +1 more
Apr 7, 2022

Tuberculosis, Pulmonary Trial in South Africa, Tanzania (H56:IC31, Placebo)

Recruiting
  • Tuberculosis, Pulmonary
  • H56:IC31
  • Placebo
  • Bellville, Cape Town, South Africa
  • +5 more
Sep 27, 2021

Tuberculosis Trial in Cape Town (H4:IC31, H56:IC31, BCG)

Completed
Has Results
  • Tuberculosis
  • H4:IC31
  • +3 more
  • Cape Town, South Africa
    Desmond Tutu HIV Foundation
Oct 28, 2019

Asthma Trial in Worldwide (AZD1402, Placebo, Short acting beta agonist (SABA) (rescue medication))

Recruiting
  • Asthma
  • Herston, Australia
  • +46 more
May 16, 2022

Latent Tuberculosis, Latent Tuberculosis Bacteriology and Histology Unknown Trial in Worcester (H56:IC31)

Completed
Has Results
  • Latent Tuberculosis
  • Latent Tuberculosis Bacteriology and Histology Unknown
  • H56:IC31
  • Worcester, South Africa
    SATVI Project Office, Brewelskloof Hospital
Aug 20, 2019

Latent Tuberculosis Bacteriology and Histology Unknown, Latent Tuberculosis Trial in Khayelitsha, Worcester (H56ug/IC31nmol,

Completed
Has Results
  • Latent Tuberculosis Bacteriology and Histology Unknown
  • Latent Tuberculosis
  • H56ug/IC31nmol
  • Placebo
  • Khayelitsha, Cape Town, South Africa
  • +1 more
Dec 3, 2019

Tuberculosis Trial in Bellville 7530, Mowbray, Johannesburg (H56:IC31, Placebo)

Completed
Has Results
  • Tuberculosis
  • H56:IC31
  • Placebo
  • Bellville 7530, Cape Town, South Africa
  • +2 more
Oct 28, 2019

Tuberculosis Trial in Cape Town, Nyanga (AERAS-404, Placebo, Bacillus Calmette-Guérin (BCG))

Completed
Has Results
  • Tuberculosis
  • AERAS-404
  • +2 more
  • Cape Town, Western Cape, South Africa
  • +1 more
Aug 22, 2019

Solid Tumors, Head Neck Cancer Trial in Shijiazhuang (SYH2051 tablets, Intensity-Modulated Radiation Therapy (IMRT))

Recruiting
  • Solid Tumors
  • Head and Neck Cancer
  • SYH2051 tablets
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Shijiazhuang, Hebei, China
    Clinical Trials Information Group
Aug 21, 2023

Spondyloarthritis Trial in Worldwide (Golimumab, Placebo)

Completed
  • Spondyloarthritis
  • Golimumab
  • Placebo
  • Brno, Czechia
  • +70 more
Jan 12, 2022

Critical Illness, Intensive Care Unit Acquired Weakness Trial (VRR)

Not yet recruiting
  • Critical Illness
  • Intensive Care Unit Acquired Weakness
  • VRR
  • (no location specified)
Oct 18, 2022

Stroke Trial in Milwaukee (Ischemic Conditioning)

Not yet recruiting
  • Stroke
  • Ischemic Conditioning
  • Milwaukee, Wisconsin
  • +1 more
Sep 6, 2023

3D Bioprinting for Personalized Treatment in Pancreatic Ductal

Recruiting
  • Pancreatic Ductal Adenocarcinoma
    • Beijing, Beijing, China
    • +1 more
    Jul 12, 2023

    Pentosan Polysulfate Sodium and Development of Pigmentary

    Completed
    • Pigmentary Maculopathy
    • +2 more
      • Titusville, New Jersey
        Janssen R&D, LLC
      Aug 17, 2022

      Herpes Zoster Subunit Vaccine During Pregnancy in Adult

      Not yet recruiting
      • Herpes Zoster
      • Data collection
      • (no location specified)
      Mar 31, 2023

      Heart Failure Acute Trial in Toulon (Conventional hospitalization, FIL-EAS ic care pathway)

      Recruiting
      • Heart Failure Acute
      • Conventional hospitalization
      • FIL-EAS ic care pathway
      • Toulon, Var, France
      • +1 more
      Oct 12, 2022

      Renal Cell Carcinoma, Bladder Cancer, MSI-H Cancer Trial in Paris (Arterial Doppler for Flow Mediated Reserve measurement)

      Recruiting
      • Renal Cell Carcinoma
      • +3 more
      • Arterial Doppler for Flow Mediated Reserve measurement
      • Paris, France
        INstitut Mutualiste Montsouris
      Aug 29, 2023

      Female Intermittent Urethral Catheterization Trial in Spain, Sweden (LoFric Elle)

      Recruiting
      • Female Intermittent Urethral Catheterization
      • LoFric Elle
      • Alicante, Spain
      • +4 more
      Aug 8, 2022

      Bladder Voiding Dysfunction Trial in Bonn, Mönchengladbach (LoFric® OrigoTM and LoFric® SenseTM)

      Recruiting
      • Bladder Voiding Dysfunction
      • LoFric® OrigoTM and LoFric® SenseTM
      • Bonn, Germany
      • +1 more
      Aug 17, 2022

      Interstitial Cystitis, Chronic Interstitial Cystitis, Bladder Pain Syndrome Trial in Winston-Salem (Pulsed Electromagnetic Field

      Completed
      Has Results
      • Interstitial Cystitis
      • +2 more
      • Pulsed Electromagnetic Field (PEMF) Therapy
      • Winston-Salem, North Carolina
        Wake Forest Health Sciences
      Dec 1, 2022

      New Echocardiographic Indicators in Treatment of Primary

      Not yet recruiting
      • Multiple Myeloma
      • Chemotherapy and/or autologous hematopoietic stem cell transplantation
      • (no location specified)
      Sep 18, 2023

      Acute Cardiovascular Adverse Events Occuring in Children Treated

      Not yet recruiting
      • Malignancies
      • +2 more
      • use of anticancer drugs in monotherapy or in combination therapy
      • (no location specified)
      Oct 27, 2022

      Interstitial Cystitis, Bladder Pain Syndrome Trial in Palo Alto (Transvaginal botulinum toxin A (BTA) injection)

      Recruiting
      • Interstitial Cystitis
      • Bladder Pain Syndrome
      • Transvaginal botulinum toxin A (BTA) injection
      • Palo Alto, California
        Urology Clinic (Stanford University), 1000 Welch Road, Suite 100
      Aug 1, 2022

      Radiation Exposure Trial in New York (Rampart IC, M1128, Lead Apron and Ancillary Shield, Rampart IC, M1128 and Lead Apron)

      Enrolling by invitation
      • Radiation Exposure
      • Rampart IC, M1128
      • +2 more
      • New York, New York
        Lenox Hill Hospital
      Jul 21, 2022

      Non-Squamous NSCLC, Squamous NSCLC Trial in Worldwide (Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody,

      Completed
      Has Results
      • Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer
      • Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody
      • +4 more
      • La Jolla, California
      • +141 more
      Apr 21, 2022